Episodes

Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO Recorded on March 12, 2024 Michael Tees, MD, MPH Director, Lymphoma Program Lymphoma Executive Committee Member, Sarah Cannon Research Institute Associate Member, Colorado Blood Cancer Institute Denver, CO Join Dr. Michael Tees from the Colorado Blood Cancer Institute, as he discusses Chimeric antigen receptor (CAR) T-cell therapy in 2024. Dr. Tees provides an overview of immunotherapy and approved indications, how to disc...

Alfred Lee, MD, PhD, Yale University, New Haven, CT Recorded on February 22, 2024 Alfred Lee, MD, PhD Professor of Medicine, Yale School of Medicine Program Director, Hematology and Medical Oncology Fellowship Chief, Division of Classical Hematology, Yale Cancer Center Yale University New Haven, CT Join us for this important and engaging episode, as Dr. Alfred Lee from Yale University addresses stress and burnout in healthcare professionals. While reflecting on his personal experience, D...

Meghna Ailawadhi, M.B.B.S., M.D., Mayo Clinic, Jacksonville, FL Recorded on December 7, 2023 Meghna Ailawadhi, M.B.B.S., M.D. Cancer Survivorship Consultant, Assistant Professor of Medicine Department of Hematology/Oncology Mayo Clinic Jacksonville, FL In this episode, Dr. Meghna Ailawadhi from the Mayo Clinic in Jacksonville, FL joins us for a conversation on survivorship care for adults. Dr. Ailawadhi discusses the importance of shared decision-making and coordination with primary care,...

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 19, 2023 Lee Greenberger, PhD Chief Scientific Officer and SVP The Leukemia & Lymphoma Society Rye Brook, NY Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to discuss highlights from the 65th American Society of Hematology (ASH) Annual Meeting in December 2023, including updates on blood cancer research, treatment, and clinical tria...

Jeffery Auletta, MD, National Marrow Donor Program® (NMDP)/Be the Match® Recorded on November 30, 2023 Jeffery Auletta, MD Senior Vice President, Patient Outcomes and Experience National Marrow Donor Program® (NMDP)/Be The Match® Chief Scientific Director CIBMTR® (Center for International Blood and Marrow Transplant Research®) National Marrow Donor Program® (NMDP)/Be The Match® Join us as Dr. Jeffery Auletta from the National Marrow Donor Program® (NMDP)/Be the Match® reflects on the hist...

Jacqueline Barrientos, MD, MS, Laura Ortiz-Ravick, MA, Kristina Lopez, LCSW Recorded on November 3, 2023 Jacqueline Barrientos, MD, MS Chief of Hematologic Malignancies Director of Oncology Research Mount Sinai Medical Center Adjunct Professor of Medicine Zucker School of Medicine at Hofstra/Northwell Miami Beach, FL Laura Ortiz-Ravick, MA Director, Outreach and Health Promotion The Leukemia & Lymphoma Society Rye Brook, NY Kristina Lopez, LCSW Information Specialist The Leukemia & Lymphoma ...

Frank Penedo, Ph.D, University of Miami, Miami, FL Recorded on August 10, 2023 Frank Penedo, Ph.D Professor, Departments of Psychology and Medicine Associate Director for Cancer Survivorship and Translational Behavioral Sciences University of Miami Sylvester Comprehensive Cancer Center Sylvester DCC Endowed Chair in Cancer Survivorship University of Miami Miami, FL Tune in as we’re joined by Dr. Frank Penedo from the University of Miami for an important discussion on considerations in s...

John Salsman, Ph.D, Wake Forest University School of Medicine, Winston-Salem, NC Recorded on June 22, 2023 John Salsman, Ph.D Director, Clinical Research in Adolescent and Young Adult (AYA) Oncology Co-Leader, Cancer Prevention and Control Program at the Atrium Health Wake Forest Baptist Comprehensive Cancer Center Professor, Department of Social Sciences and Health Policy at the Wake Forest University School of Medicine Winston-Salem, NC In this episode, Dr. John Salsman from Wake Fore...

Tung Wynn, MD, University of Florida, Gainesville, FL and Braulio Hernandez Recorded on June 10, 2023 Join Dr. Tung Wynn from the University of Florida, and Braulio Hernandez, a childhood cancer advocate and AYA survivor of Hodgkin Lymphoma, as they discuss the unique experiences of adolescents and young adults from active treatment to survivorship. Dr. Wynn and Braulio reflect on the physical and psychosocial long-term and late effects of treatment, strategies to support survivors and their f...

Chasity Burrows Walters, PhD, RN, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on April 13, 2023 Chasity Burrows Walters, PhD, RN Vice President, Educational, Clinical, & Patient Communication Memorial Sloan Kettering Cancer Center New York, NY In this important conversation, Dr. Chasity Burrows Walters from Memorial Sloan Kettering Cancer Center discusses the barriers that persons within the LGBTQI+ community experience in accessing healthcare and the impact of discrimina...

Ehab Atallah, MD, Medical College of Wisconsin, Milwaukee, WI Recorded on January 24, 2023 Ehab Atallah, MD Professor of Medicine Associate Director, Cancer Service Line Section Head, Hematologic Malignancies Division of Hematology and Oncology Medical College of Wisconsin Milwaukee, WI In this episode, Dr. Ken Miller sits down with Dr. Ehab Atallah, from the Medical College of Wisconsin, to discuss chronic myeloid leukemia (CML) including the development of tyrosine kinase inhibitors (...

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 19, 2022 Lee Greenberger, PhD Chief Scientific Officer and SVP The Leukemia & Lymphoma Society Rye Brook, NY In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide an update on the information presented at the 64th American Society of Hematology (ASH) Annual Meeting, including leukemia, lymphoma, myeloma, MDS, an...

Shayna Sarosiek, MD, Dana Farber Cancer Institute, Boston, MA Recorded on December 6, 2022 Shayna Sarosiek, MD Assistant Professor Harvard Medical School Dana Farber Cancer Institute Boston, MA Waldenström Macroglobulinemia (WM) is a rare blood cell cancer characterized by an excess number of abnormal white blood cells in the bone marrow. How does WM fit into the spectrum of other blood cancer diseases? Who is at risk? What are the genetic factors? Dr. Shayna Sarosiek, from the Dana-Farbe...

Sattva S. Neelapu, MD, M.D. Anderson Cancer Center, Houston, TX Recorded on December 16, 2022 Sattva S. Neelapu, MD Professor and Deputy Chair Department of Lymphoma and Myeloma The University of Texas M.D. Anderson Cancer Center Houston, TX Chimeric antigen receptor (CAR) T-cell therapy has generated impressive results in hematologic malignancies, with many drugs still in clinical trials. In this episode, Dr. Sattva S. Neelapu from MD Anderson Cancer Center, joins us to discuss updates o...

Daphne Friedman, MD, Durham VA Health Care System, Durham, NC Recorded on October 20, 2022 Daphne Friedman, MD Staff Oncologist, Durham VA Health Care System Associate Professor, Duke University School of Medicine Durham, NC In Part II of Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia, Dr. Daphne Friedman, from the Durham VA Health Care System in North Carolina, discusses the importance of a relationship between the provider and the patient when it comes to sha...

Eytan M. Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on October 7, 2022 Eytan M. Stein, MD Chief, Leukemia Service Director, Program for Drug Development in Leukemia Associate Attending Physician Leukemia Service, Department of Medicine Memorial Sloan Kettering Cancer Center New York, NY Dr. Eytan Stein, from Memorial Sloan Kettering Cancer Center, joins us to reflect on breakthroughs in acute myeloid leukemia, including updates in treatment, long-term and l...

Saad Z. Usmani, MD, MBA, FACP, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on September 30, 2022 Saad Z. Usmani, MD, MBA, FACP Hematologic Oncologist Chief, Myeloma Service Memorial Sloan Kettering Cancer Center New York, NY Join us for this special episode, recorded live from the Tenth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conference attendee, Lauren Berger, Senior Director of Professional Education and Engagement at The Le...

Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX Recorded on September 6, 2022 Naveen Pemmaraju, MD Associate Professor Department of Leukemia Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston, TX Join us as Dr. Naveen Pemmaraju from MD Anderson Cancer Center, returns to discuss blastic plasmacytoid dendritic cell neoplasms (BPDCN)! In this episode, Dr. Pemmaraju provides an overview of BPDCN, including major updates...

Jason Gotlib, MD, Stanford University School of Medicine, Palo Alto, CA Recorded on July 19, 2022 Jason Gotlib, MD Professor of Medicine in the Division of Hematology Stanford Cancer Institute Stanford University School of Medicine Palo Alto, CA Mastocytosis is a rare and complex disease. In this special episode, Dr. Jason Gotlib from the Stanford University School of Medicine in Palo Alto, CA, discusses an overview of the disease, including its subtypes, clinical presentations, and treat...

Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ Recorded on June 30, 2022 Rafael Fonseca, MD, Chief Innovation Officer Getz Family Professor of Cancer Mayo Clinic Phoenix, AZ In this episode, Dr. Rafael Fonseca, from the Mayo Clinic in Arizona, joins Dr. Ken Miller to breakdown the complex and complicated nature of genomics and molecular profiling. He discusses the role of molecular profiling in treating blood cancers, explains how we integrate genomics into the standard of care for people l...

Kevin C. Oeffinger, MD, FASCO, Duke University Medical Center, Durham, NC Recorded on June 9, 2022 Kevin C. Oeffinger, MD, FASCO Director, Duke Cancer Institute (DCI) Center for Onco-Primary Care Director, DCI Supportive Care and Survivorship Center Professor of Medicine, Division of Medical Oncology Department of Medicine Duke University Medical Center Durham, NC Children diagnosed with cancer are a heterogenous population experiencing different cancer diagnoses and therapies. Each jou...

Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on May 20, 2022 Gwen L. Nichols, MD Chief Medical Officer The Leukemia & Lymphoma Society Rye Brook, NY Through the LLS Children’s Initiative, The Leukemia & Lymphoma Society (LLS) is setting out to fundamentally change how children with blood cancer are treated and cared for. For children and their families, LLS provides free education, support services, financial assistance, advocacy efforts, and has increased i...

Zalman Suldan, MD, PhD, Hackensack University Medical Center – Hackensack Meridian Health, Hackensack, NJ Recorded on May 3, 2022 Zalman Suldan, MD, PhD Attending Physician Hackensack University Medical Center Hackensack Meridian Health Hackensack, NJ The primary care physician plays an important role in the treatment of patients living with a chronic blood disorder, from early diagnosis to appropriate referral to a hematologist-oncologist, from coordination of care to goals of therapy. I...

Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX Recorded on April 8, 2022 Rayne H. Rouce, MD, BS Associate Professor Department of Pediatrics Texas Children’s Cancer Center for Cell and Gene Therapy Baylor College of Medicine Houston, TX As CAR T-cell therapy continues to evolve in new and exciting ways, new indications are approved and treatment toxicities reduced. In this episode, Dr. Rayne Rouce, from the Texas Children’s Cancer Center for...